Ineffectiveness of myrrh-derivative mirazid against schistosomiasis and fascioliasis in humans;Inefficacité du mirazid (à base de myrrhe) dans le traitement de la schistosomiase et de la fasciolase chez l'homme

Eastern Mediterranean Health Journal

Volumn 16, Issue 9, 2010, Pages 932-936

  Osman, M M ^a   El Taweel, H A ^a   Shehab, A Y ^a   Farag, H F ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISCHISTOSOMAL AGENT; FASCIOLICIDE; MIRAZID; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TOLERABILITY; EGYPT; FASCIOLA; FASCIOLIASIS; FEMALE; FOLLOW UP; HUMAN; INFECTION CONTROL; MALE; NONHUMAN; QUALITY CONTROL; RECOMMENDED DRUG DOSE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 78751605636     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.9.932     Document Type: Article

References (25)

1. Massoud AM, Galal MM, Bennett JL. Experimental studies demonstrating the anti-schistosomal activity of myrrh, cammiphora molmol. Proceedings of the 45th Annual Meeting of the American Society of Tropical Medicine and Hygiene, 1996, Baltimore, Maryland. Supplement to American Journal of Tropical Medicine and Hygiene, 55(2 suppl.):233-234.
2. Massoud AM, Salama O, Bennett JL. Efficacy, toxicity and side effects of a new antischistosomal drug derived from myrrh. Proceedings of the 46th Annual Meeting of the American Society of tropical Medicine and Hygiene.1997, Florida. Supplement to American Journal of Tropical Medicine and Hygiene, 57(3 Suppl.):244.
3. Sheir Z et al. A safe, effective, herbal antischistosomal therapy derived from myrrh. American Journal of Tropical Medicine and Hygiene, 2001, 65:700-704.
4. Massoud A et al. Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). American Journal of Tropical Medicine and Hygiene, 2001, 65:96-99.
5. Badria F et al. Mirazid: a new schistosomicidal drug. Pharmaceutical Biology, 2001, 39:127-131.
6. Gaballah M et al. Control of schistosomiasis in a rural area using a new safe effective herbal treatment. Journal of Environmental Science, 2001, 21:63-84.
7. Motawea SM et al. Control of Fasciola in an Egyptian endemic rural area by a safe, effective fasciolicidal herbal drug. Journal of Environmental Science, 2001, 21:85-104.
8. Hamed MA, Hetta MH. Efficacy of Citrus reticulata and Mirazid in treatment of Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz, 2005, 100:771-778
9. Mahmoud M S, Abou-El Dobal S, Soliman K. Immune Response in Fasciola gigantica experimentally infected rabbits treated with either carnosine or Mirazid®. Research Journal of Parasitology, 2008, 3:40-49
10. El Baz MA et al. Clinical and parasitological studies on the efficacy of Mirazid in treatment of schistosomiasis haematobium in Tatoon, Etsa Center, El Fayoum Governorate. Journal of the Egyptian Society of Parasitology, 2003, 33:761-767.
11. Abo-Madyan AA, Morsy TA, Motawea SM. Efficacy of myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt. Journal of the Egyptian Society of Parasitology, 2004, 34:423-446.
12. Abo-Madyan AA et al. Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate. Journal of the Egyptian Society of Parasitology, 2004, 34:807-818.
13. Soliman OE et al. Evaluation of myrrh (Mirazid) therapy in fascioliasis and intestinal schistosomiasis in children: immunological and parasitological study. Journal of the Egyptian Society of Parasitology, 2004, 34:941-966.
14. Massoud AM et al. Evaluation of schistosomicidal activity of myrrh extract: parasitological and histological study. Journal of the Egyptian Society of Parasitology, 2004, 34(3 Suppl.):1051-1076.
15. El-Mathal EM, Fouad MA. Human fascioliasis among immigrant workers in Saudi Arabia. Journal of the Egyptian Society of Parasitology, 2005, 35(3 Suppl.):1199-1207.
16. Botros S et al. Lack of evidence for an antischistosomal activity of myrrh in experimental animals. American Journal of Tropical Medicine and Hygiene, 2004, 71:206-210.
17. Botros S et al. Efficacy of Mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. American Journal of Tropical Medicine and Hygiene, 2005, 72:119-123.
18. Barakat R, Elmorshedy H, Fenwick A. Efficacy of myrrh in the treatment of human schistosomiasis mansoni. American Journal of Tropical Medicine and Hygiene, 2005, 73:365-367.
19. Allam AF et al. Assessing the marginal error in diagnosis and cure of Schistosoma mansoni in areas of low endemicity using Percoll and PCR techniques. Tropical Medicine and International Health, 2009, 14(3):316-321.
20. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Revista do Instituto de Medicina Tropical de São Paulo, 1972, 14:397-400.
21. Additional techniques for stool examination. In: Garcia LS, ed. Diagnostic medical parasitology, 4th ed. Washington DC, American Society for Microbiology Press, 2001:786-801.
22. Southgate VR et al. Towards control of schistosomiasis in sub-Saharan Africa. Journal of Helminthology, 2005, 79:181-185.
23. Utzinger J et al. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Tropical Medicine and International Health, 2000, 5:771-778.
24. Utzinger J et al. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology, 2001, 122:537-544.
25. El-Morshedy H et al. Intra-specimen and day-to-day variations of Fasciola egg counts in human stools. Eastern Mediterranean Health Journal, 2002, 8:619-625.